Medically reviewed by Drugs.com. Last updated on Jan 15, 2022.
Risk of death is increased in elderly patients with dementia-related psychosis treated with antipsychotic drugs. Paliperidone palmitate is not approved for use in patients with dementia-related psychosis .
Commonly used brand name(s)
In the U.S.
- Invega Hafyera
- Invega Sustenna
- Invega Trinza
Available Dosage Forms:
- Suspension, Extended Release
Therapeutic Class: Antipsychotic
Chemical Class: Benzisoxazole
Uses for paliperidone
Paliperidone injection is used to treat the symptoms of psychotic (mental) disorders, including schizophrenia. Invega Trinza® and Invega Hafyera™ are used if patients have been treated with Invega Sustenna® for at least 4 months. Invega Hafyera™ is also used if patients have been treated with Invega Trinza® for at least 3 months. Invega Sustenna® may also be used alone or in combination with other medicines to treat schizoaffective disorder. Paliperidone should not be used to treat behavioral problems in older adults who have dementia.
Paliperidone is to be given only by or under the direct supervision of your doctor.
Before using paliperidone
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For paliperidone, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to paliperidone or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of paliperidone injection in the pediatric population. Use of Invega Trinza® or Invega Hafyera™ is not recommended. Safety and efficacy have not been established.
Geriatric
Appropriate studies pe..
